Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (321)	3/20/1998 7:55:00 AM
From: Linda Kaplan	Read Replies (3) \| Respond to of 2911

Ken, In the following news release, I took the phrase "filed a complaint" to mean filed in court. I think it's worthwhile to ask, to see if they did that or not. What do you think this means in terms of what our company's subsidiary did do? Certainly this can only mean more money for MDIX nor no more money if the case is lost. I can't imagine how it can be understood negatively for MDIX. What am I missing, Ken and Sandra? ============================================================ News Alert from Dow Jones Online News via Quote.com Topic: (NASDAQ:ADRX) Andrx Corp, (NASDAQ:MDIX) Medical Diagnostics, Quote.com News Item #5820084 Headline: Medix Unit Accuses Andrx Of Theft, Seeks $397 Million In Damages ====================================================================== DENVER -(Dow Jones)- A unit of health-care services concern Medix Resources Inc. Thursday accused Andrx Corp. and its CyBear Inc. unit of theft and misappropriation of medical software and Internet medical communications technology, and demanded nearly $397 million in damages. Andrx (ADRX), which researches and develops controlled release oral drugs, rejected Medix's claims, saying the company's case has "no basis in substantial fact or legal support." Medix's Cymedix Lynx Corp. unit filed the complaint, saying its demand represents damages on the projected income for the first five years of $132.2 million Cymedix expects to lose as a direct result of the alleged activities conducted by Andrx, Cybear and individuals employed by Andrx. Details about the products at question weren't provided by either firm. Medix (MDIX) said it filed a final U.S. patent application last October for the software and technology. Copyright (c) 1998 Dow Jones & Company, Inc. All Rights Reserved.